Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly)

Study to Evaluate the Effect of Intravenous (IV) Paricalcitol (Zemplar) on Cardiac Morbidity in Patients With Chronic Kidney Disease (CKD) Stage 5 Over 2 Years

NCT01073462 ·Status: COMPLETED

Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)

NCT01224782 ·Status: COMPLETED

A Study to Evaluate the Safety and Efficacy of Paricalcitol Capsules in Reducing Serum Intact Parathyroid Hormone Levels in End Stage Renal Disease Subjects on Peritoneal Dialysis

NCT00646035 ·Status: COMPLETED ·Phase: PHASE3

Observational Study to Evaluate the Time to Achieving the Maintenance Dose of Zemplar® (Paricalcitol Injection) in the Treatment of Patients Suffering From End-stage Renal Disease and Severe Over-reactivity of the Parathyroid Glands

NCT01273597 ·Status: COMPLETED

Long-Term Therapy Outcomes When Treating Chronic Kidney Disease (CKD) Patients With Paricalcitol in German and Austrian Clinical Practice

NCT01083849 ·Status: COMPLETED

Study to Assess Patient Management Practices and Quality of Life With Paricalcitol Capsules in the Treatment of Secondary Hyperparathyroidism in Stage 3-5 Chronic Kidney Disease Patients Not Yet on Dialysis

NCT01265992 ·Status: COMPLETED

Study to Compare Initial Dosing Parameters of Zemplar in Stage V Chronic Kidney Disease Subjects on Hemodialysis

NCT00091481 ·Status: COMPLETED ·Phase: PHASE4

Evaluate the Survival Benefits of Zemplar Versus Calcijex in Subjects w/ Stage V Chronic Kidney Disease on Hemodialysis

NCT00062699 ·Status: TERMINATED ·Phase: PHASE4

Paricalcitol Oral Therapy in Predialysis CKD Patients. The Greek Experience

NCT01083186 ·Status: COMPLETED

The Effect of Paricalcitol on Creatinine Filtration, Secretion and Glomerular Filtration Rate

NCT01163162 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy of Paricalcitol Capsules in Decreasing Serum Parathyroid Hormone Levels in Children Aged 10-16 With Chronic Kidney Disease (CKD)

NCT01020487 ·Status: COMPLETED ·Phase: PHASE3

Follow-up Patients With End Stage Renal Disease Receiving Zemplar to Prevent and Treat Secondary Hyperparathyroidism

NCT01081665 ·Status: COMPLETED

A Study of Zemplar® Injection and Hectorol® Injection on Intestinal Absorption of Calcium in Chronic Kidney Disease

NCT00257920 ·Status: COMPLETED ·Phase: PHASE4

The Effect of Paricalcitol Capsules on Reducing Albuminuria in Patients With Type 2 Diabetic Nephropathy Being Treated With Renin-angiotensin System Inhibitors

NCT00421733 ·Status: COMPLETED ·Phase: PHASE2

Parathyroid Hormone Levels in Relation to the Phosphorus Content of Meals

NCT00018135 ·Status: COMPLETED ·Phase: NA

Observational Program of Zemplar in Patients With End Stage Chronic Kidney Disease and Parathyroid Disorder on Hemodialysis in the Russian Federation

NCT01401478 ·Status: COMPLETED

Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of Calcium

NCT00073710 ·Status: COMPLETED ·Phase: PHASE4

Sevelamer and Secondary Hyperparathyroidism in Chronic Kidney Disease

NCT01191762 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin D

NCT00977080 ·Status: COMPLETED ·Phase: PHASE4

Study of Protective Effects of Paricalcitol on Inner Layer of Vessels and Its Protective Effect on Inflammation

NCT00428246 ·Status: COMPLETED ·Phase: NA

A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis

NCT01382212 ·Status: COMPLETED ·Phase: PHASE3

DePTH: De-emphasize PTH

NCT06288451 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Post Marketing Observational Study on Paricalcitol IV Administered to Venezuelan Patients

NCT01758289 ·Status: TERMINATED

A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Patients on Dialysis

NCT00042653 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate Safety of Vitamin D Receptor Activators in Patients Ages 0 to 16 With Chronic Kidney Disease Stage 5 Receiving Peritoneal Dialysis Within Current Clinical Practice

NCT01134315 ·Status: TERMINATED